又一重量级低空经济产业联盟成立；优必选推出一款工业人形机器人｜数智早参

Group 1 - The "East China (including Yangtze River Delta) Low Altitude Economy Industry Alliance" was officially established during the "2025 International Low Altitude Economy Expo" held in Shanghai on July 23, 2025. This alliance includes seven civil aviation and unmanned aerial vehicle test zones in East China and renowned universities such as Nanjing University of Aeronautics and Astronautics and Shanghai Jiao Tong University [1] - The establishment of the alliance marks a significant milestone for the low altitude economy in East China and is a crucial step for China to seize the global high ground in the low altitude industry [1] Group 2 - UBTECH has launched the "Walker S2," a full-size industrial humanoid robot designed for smart manufacturing scenarios. This robot features the BrainNet 2.0, an iterative group brain network, and the Co-Agent technology, which is the world's first intelligent technology specifically for industrial humanoid robots [2] - The Walker S2 stands 1.76 meters tall and can perform human-like walking and precise operations. Its autonomous battery swapping technology allows for 24/7 uninterrupted operation [2] - The introduction of Walker S2 represents a leap in single-machine capabilities and initiates a new paradigm of collaborative intelligence among industrial robots, potentially transforming the productivity system in smart manufacturing [2] Group 3 - Nanjing announced its plan to become a national hub for brain-computer interface (BCI) industry during the BCI industry cultivation conference on July 23, 2025. The draft action plan aims for Nanjing to become a research and transformation highland in the BCI field by 2027 and an innovation highland by 2030 [3] - Research institutions predict that the market size of China's BCI industry could exceed 120 billion yuan by 2040 [3] - This initiative reflects the local government's ambition to develop cutting-edge industries and signals the national intent to accelerate the cultivation of future industries. However, challenges such as technological maturity, ethical standards, and clinical application barriers need to be addressed for successful industry development [3]